NSE - SMEListed
Ambey Laboratories Limited
Company websiteAmbey Laboratories Limited is launching an IPO sized at ₹65,70,000 crore. The raise comprises a fresh issue of ₹59,28,000 crore and an OFS of ₹3,12,000 crore, together representing roughly 2000 shares.
Subscription is open from 04-07-2024 to 08-07-2024. The allotment is expected on 09-07-2024, and listing is targeted for 11-07-2024. Note: fresh issue proceeds typically go to the company while OFS proceeds go to selling shareholders.
Start Date04-07-2024
End Date08-07-2024
Listing Date11-07-2024
Allotment Date09-07-2024
Current Price₹85
GMP₹28 (41.18%)
Lot Size2000 Shares
Subscription159.71 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹65 - ₹68
Pre Issue₹1,86,88,819
Post Issue₹2,52,40,819
Issue Size₹65,70,000
(aggregating up to 44.68 Cr)
(aggregating up to 44.68 Cr)
Fresh Issue₹59,28,000
(aggregating up to 40.31 Cr)
(aggregating up to 40.31 Cr)
Offer For Sale₹3,12,000
(aggregating up to 2.12 Cr)
(aggregating up to 2.12 Cr)
The Grey Market Premium (GMP) for Ambey Laboratories Limited is currently around ₹28 (41.18%). This indicates an estimated listing price of approximately ₹93 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
21 Nov 2025, 13:03 | ₹68 | ₹28 | ₹96 (41.18%) |
06 Mar 2025, 11:37 | ₹68 | ₹28 | ₹96 (41.18%) |
Financials overview in Lakhs
Here is a quick look at the recent financial performance of Ambey Laboratories Limited . The numbers below ( in Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Jun-24 | Mar-23 | Mar-22 |
|---|---|---|---|
EPS | 3.33 | 2.57 | 7.08 |
ROE | 20.80 | 21.40 | 63.82 |
ROCE | 13.14 | 12.75 | 12.53 |
RONW | 20.80 | 21.40 | 63.82 |
PRE IPO(PE) | 27.81 | 0 | 0 |
POST IPO(PE) | 23.54 | 0 | 0 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹8.51 | 526.97 | 61.92 |
RETAIL | ₹14.85 | 2883.8 | 194.20 |
Total | ₹23.36 | 3410.77 | 146.01 |
Application Wise Breakup (Approx. no of Apps)
| Category | Reserved | Applied | Times |
|---|---|---|---|
Total | 0 | 0 | 0.00 |
The IPO reservation for Ambey Laboratories Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
RETAIL | 33.24% | 21,84,000 |
NII (HNI) | 14.25% | 9,36,000 |
QIB | 19.05% | 12,52,000 |
Anchor | 28.44% | 18,68,000 |
Market Maker | 5.02% | 3,30,000 |
TOTAL | 100.00% | 65,70,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 2,000 | ₹1,36,000 | |
HNI | 2 | 4,000 | ₹2,72,000 |
Below you can find the official contact details of Ambey Laboratories Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@ambeylab.com
Phone: 0124-4000788
Website: http://www.ambeylab.com/
Address: Ground Floor, Property No.555 Tarla Mohalla, Ghitorni, West Delhi, New Delhi, -110030
IPO Registrar
Name: Link Intime India Private Limited
Phone: +91-22-4918 6270